Waters Corporation has underperformed the Dow over the past year, and analysts are cautious about the stock’s prospects.
Investors in Agilent Technologies, Inc. A need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $80.00 Call had some of the highest implied...
Mettler-Toledo International has outperformed its industry peers this year, yet Wall Street analysts maintain a cautious outlook on the stock's future potential.
IQVIA Holdings has considerably underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.
Despite Agilent Technologies’ recent underperformance relative to the S&P 500 Index, Wall Street analysts remain moderately optimistic about the stock’s prospects.
Danaher has underperformed the Medical Devices industry, though Wall Street analysts remain strongly optimistic about its future prospects.
Agilent Technologies has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
The new structure organizes the company’s businesses according to its end markets and customers.
Agilent’s shares have declined 3.25% for the year-to-date period, underperforming the broader market.